Treatment recommendations for chronic myeloid leukemia
Michele Baccarani1, Fausto Castagnetti2, Gabriele Gugliotta2
1Department of Hematology and Oncology "L. and A. Seràgnoli", University of Bologna, Bologna, Italy.
Mediterranean Journal of Hematology and Infectious Diseases
|January 24, 2014
Summary
Chronic myeloid leukemia (CML) treatment evolved from radiation and drugs to stem cell transplants and interferon. Tyrosine kinase inhibitors (TKIs) now offer prolonged survival and improved quality of life for most CML patients.
Area of Science:
- Hematology
- Oncology
- Pharmacology
Background:
- Early chronic myeloid leukemia (CML) treatments like radiation and chemotherapy offered limited success.
- Allogeneic stem cell transplantation (alloSCT) and interferon-alfa represented significant advancements, improving cure rates and remission.
- The advent of tyrosine kinase inhibitors (TKIs) revolutionized CML management, offering molecular remissions and prolonged survival.
Purpose of the Study:
- To review the historical evolution of CML treatment strategies.
- To discuss the role of alloSCT and emerging TKI therapies.
- To highlight current and future therapeutic goals in CML management.
Main Methods:
- Literature review of CML treatment modalities.
- Analysis of historical treatment outcomes.
- Discussion of current therapeutic guidelines and experimental strategies.
Main Results:
- CML treatment has progressed from palliative care to curative and disease-controlling therapies.
- TKIs have become the cornerstone of CML treatment, achieving high molecular remission rates.
- Newer TKIs and strategies aim for treatment-free remission and a quality of life comparable to healthy individuals.
Conclusions:
- CML therapy has dramatically improved, offering prolonged survival and better quality of life.
- Continuous updates in treatment recommendations are essential due to evolving therapies and cost considerations.
- Future CML treatment aims for complete disease eradication and treatment-free remission.
Related Concept Videos
01:15Differentiation of Common Myeloid Progenitor Cells
3.1K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.1K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:21Stem Cell Therapy for Tissue Regeneration
3.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
3.8K
02:57Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
755
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
755
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
689
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
689